Literature DB >> 15181610

Infection, immune function, and functional gut disorders.

Robin C Spiller1.   

Abstract

Mesh：

Year:  2004        PMID： 15181610     DOI： 10.1016/s1542-3565(04)00159-4

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  11 in total

1.  Do probiotics improve symptoms in patients with irritable bowel syndrome?

Authors:  Peter J Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 2.  Irritable bowel syndrome: update on colonic neuromuscular dysfunction and treatment.

Authors:  William D Chey; Brooks D Cash
Journal:  Curr Gastroenterol Rep       Date:  2006-08

Review 3.  Irritable bowel syndrome: recent and novel therapeutic approaches.

Authors:  Viola Andresen; Michael Camilleri
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 4.  Current and novel therapeutic options for irritable bowel syndrome management.

Authors:  M Camilleri; V Andresen
Journal:  Dig Liver Dis       Date:  2009-08-08       Impact factor: 4.088

Review 5.  LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin.

Authors:  M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2010-12-15       Impact factor: 3.598

6.  Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.

Authors:  Raffaele Capasso; Pierangelo Orlando; Ester Pagano; Teresa Aveta; Lorena Buono; Francesca Borrelli; Vincenzo Di Marzo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

7.  Gastric Enterovirus Infection: A Possible Causative Etiology of Gastroparesis.

Authors:  Jodie A Barkin; Frank Czul; Jamie S Barkin; Nancy G Klimas; Irma R Rey; Baharak Moshiree
Journal:  Dig Dis Sci       Date:  2016-06-25       Impact factor: 3.199

8.  Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome.

Authors:  Jeroen Aerssens; Michael Camilleri; Willem Talloen; Leen Thielemans; Hinrich W H Göhlmann; Ilse Van Den Wyngaert; Theo Thielemans; Ronald De Hoogt; Christopher N Andrews; Adil E Bharucha; Paula J Carlson; Irene Busciglio; Duane D Burton; Thomas Smyrk; Raul Urrutia; Bernard Coulie
Journal:  Clin Gastroenterol Hepatol       Date:  2008-02       Impact factor: 11.382

9.  A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome.

Authors:  Wolfgang Kruis; Sigrun Chrubasik; Stephan Boehm; Christiane Stange; Juergen Schulze
Journal:  Int J Colorectal Dis       Date:  2011-12-02       Impact factor: 2.571

10.  The Food-Specific Serum IgG Reactivity in Major Depressive Disorder Patients, Irritable Bowel Syndrome Patients and Healthy Controls.

Authors:  Hanna Karakula-Juchnowicz; Mirosława Gałęcka; Joanna Rog; Anna Bartnicka; Zuzanna Łukaszewicz; Pawel Krukow; Justyna Morylowska-Topolska; Karolina Skonieczna-Zydecka; Tomasz Krajka; Kamil Jonak; Dariusz Juchnowicz
Journal:  Nutrients       Date:  2018-04-28       Impact factor: 5.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.